← Open Payments lookup

JULIA KIMBROUGH: Open Payments

NPI 1619417581 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$809 in 35 payments from 14 companies in 2025. Trend: 2023 $819 · 2024 $686 · 2025 $809

Food & beverage: $809
CompanyPaymentsAmount
Novo Nordisk Inc10$233
Boston Scientific Corporation3$118
PFIZER INC.4$80
ABBVIE INC.3$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$51
AstraZeneca Pharmaceuticals LP2$48
Astellas Pharma US Inc2$41
Abbott Laboratories2$38
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
TMS NeuroHealth Centers Inc.1$23

Products named: Ozempic, Wegovy, FARAPULSE, VRAYLAR, Rybelsus, XIFAXAN, AIRSUPRA, WaveWriter Alpha Prime 16.

Industry payments across MD — which companies pay providers there.